Status:
COMPLETED
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Lead Sponsor:
Allergan
Conditions:
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in patients with glaucoma or ocular hypertension
Eligibility Criteria
Inclusion
- Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes
- Patient requires IOP-lowering drug in both eyes
Exclusion
- Uncontrolled medical condition
- Contraindication to beta-adrenoceptor antagonist therapy
Key Trial Info
Start Date :
August 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2003
Estimated Enrollment :
520 Patients enrolled
Trial Details
Trial ID
NCT00332540
Start Date
August 1 2001
End Date
August 1 2003
Last Update
May 30 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rochester, New York, United States
2
Sherbrooke, Quebec, Canada